Affinia Therapeutics has received the US Food and Drug Administration (FDA) fast track designation (FTD) for AFTX-201, a genetic medicine under investigation for treating Bcl-2-associated athanogene 3 ...

Avoid unnecessary tests and antibiotics by applying evidence-based, cost-conscious infectious-disease decision-making, with ...

The FDA has granted Fast Track designation to AFTX-201 for the treatment of BAG3-associated dilated cardiomyopathy.

The kidney filters blood to remove waste products and excess water. In addition, the kidney plays a role in acid-base (pH) ...

Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced presentations on SGT-003, its ...

Although HIV infection remains a global public health challenge, ART has transformed it from a fatal illness to a manageable lifetime condition for those who are successfully being treated.Initially, ...

A case of a 45-year-old construction worker with a history of intravenous drug use, homelessness, and occasional alcohol and tobacco use.

It robs 12% to 24% of people over 65 of their independence, turning simple daily tasks into monumental hurdles. Currently, we ...

Gemcitabine intravesical system+intravenous cetrelimab did not improve bladder-intact event-free survival or OS for pts with MIBC who did not receive radical cystectomy.

Esperion has acquired Corstasis Therapeutics and its nasal spray Enbumyst, which was approved by the FDA six months ago.

As in the study reported by Shahi, successful pathogen identification greatly increased the chances of successful treatment. Defining failure as reoperation for infection or use of chronic antibiotic ...

A guide to Medicare coverage for breast cancer diagnosis and treatment, including cost differences between Original Medicare ...